Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), Shell plc ...

Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Keros Therapeutics (KROS – Research Report) today and set a price target of ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...

Explore some of the best blue-chip ETFs to buy for investors who want to sleep well at night (SWAN) during their retirement ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...

Salesforce stock won an upgrade to buy from TD Cowen, which pointed to momentum for its new artificial intelligence platform.

Discover investment opportunities in lesser-covered stocks like Arcus Biosciences, Sarepta Therapeutics, and Edison International.

Gildan Activewear Inc. closed C$0.27 below its 52-week high of C$71.55, which the company achieved on January 15th.

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...